Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Identification of additional complementation groups that regulate genomic instability

I J Hall1, D Gioeli, B E Weissman

  • 1Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill, Chapel Hill, USA.

Genes, Chromosomes & Cancer
|October 23, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epithelial-Stromal Interactions in Barrett's Esophagus Modeled in Human Organ Chips.

Gastro hep advances·2024
Same author

Prostate cancer treatment ascertained from several sources: analysis of disagreement and error.

Annals of oncology : official journal of the European Society for Medical Oncology·2011
Same author

Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases.

Oncogene·2010
Same author

Restoration of PTEN expression alters the sensitivity of prostate cancer cells to EGFR inhibitors.

The Prostate·2008
Same author

Genetic and epigenetic changes in mammary epithelial cells identify a subpopulation of cells involved in early carcinogenesis.

Cold Spring Harbor symposia on quantitative biology·2006
Same author

Conditional expression of PTEN alters the androgen responsiveness of prostate cancer cells.

The Prostate·2006
Same journal

Biphenotypic Sinonasal Sarcoma With a Novel PAX3::MAML2 Fusion.

Genes, chromosomes & cancer·2026
Same journal

An Affordable and Efficient In-House Approach for Detecting Gene Fusions in Bone and Soft Tissue Tumors Using a Custom Capture Panel and Nanopore Sequencing.

Genes, chromosomes & cancer·2026
Same journal

PKMYT1 in Cancer: Beyond Cell Cycle Checkpoints to Context-Dependent Therapeutic Vulnerability.

Genes, chromosomes & cancer·2026
Same journal

Associations of Dietary Intake Traits and Aging Indicators With Colorectal Cancer: A Mendelian Randomization Study.

Genes, chromosomes & cancer·2026
Same journal

Primary Tumor-Associated Loss of the Y Chromosome and Clinical Outcome in Metastatic Colorectal Cancer.

Genes, chromosomes & cancer·2026
Same journal

Cytogenetic and Molecular Analysis of a "Double-Hit" RUNX1 Including a RUNX1 p.Trp279* and a Cryptic Novel t(6;21)(q25;q22)/RUNX1::ARID1B in Acute Myeloid Leukemia.

Genes, chromosomes & cancer·2026
See all related articles

Gene amplification is a recessive trait in tumor cells, influenced by factors beyond TP53. Further research identified multiple genetic defects regulating this complex process.

Area of Science:

  • Genetics
  • Molecular Biology
  • Cancer Research

Background:

  • Gene amplification is a significant mechanism in cancer development.
  • The role of TP53 (p53) in regulating amplification frequency has been previously investigated.
  • Tumor cell lines exhibit varying abilities to amplify genes, suggesting complex regulatory mechanisms.

Purpose of the Study:

  • To determine if gene amplification is a recessive genetic trait in tumor cell lines.
  • To identify genetic factors that regulate gene amplification frequency.
  • To delineate complementation groups of tumor cell lines with defects in amplification regulation.

Main Methods:

  • Somatic cell hybridization was used to create normal fibroblast x tumor and tumor x tumor hybrids.
  • Complementation analysis was performed on somatic cell hybrids.

Related Experiment Videos

  • Amplification frequencies were measured in parental cell lines and their hybrids.

    • Main Results:

    • Gene amplification was confirmed as a recessive genetic trait in the examined tumor cell lines.
    • Hybridization with normal fibroblasts suppressed amplification frequencies 10-100 fold.
    • Analysis of tumor x tumor hybrids revealed at least two distinct complementation groups, indicating defects independent of TP53.

    Conclusions:

    • Gene amplification is regulated by recessive genetic factors in tumor cells.
    • TP53 activity is not the sole determinant of amplification frequency.
    • Multiple genetic variables contribute to the regulation of gene amplification, suggesting complex pathways involved in this cancer-related phenomenon.